References
- Rakash S, Rana F, Rafiq S et al. Role of proteases in cancer: a review. Biotechnol Mol Biol Rev. 2012 Oct;7(4):90–101. DOI:https://doi.org/10.5897/bmbr11.027.
- Verma S, Dixit R, Pandey KC. Cysteine proteases: modes of activation and future prospects as pharmacological targets. Front Pharmacol. 2016 Apr;7(APR):107. DOI:https://doi.org/10.3389/fphar.2016.00107.
- Ramli ANM, Aznan TNT, Illias RM. Bromelain: from production to commercialisation. J Sci Food Agric. Mar. 30, 2017;97(5):1386–1395. DOI:https://doi.org/10.1002/jsfa.8122. John Wiley and Sons Ltd.
- Pavan R, S J, Kumar A. Properties and therapeutic application of bromelain: a review. Biotechnol Res Int. 2012Dec;2012:1–6. DOI:https://doi.org/10.1155/2012/976203.
- Musselman LJ., ed. 2. Encyclopedia of common natural ingredients used in food, drugs, and cosmetics. Albert, T Leung, and Steven, Foster. Econ Bot 1996; 50-422. DOI:https://doi.org/10.1007/BF02866524.
- Banerjee S, Arora A, Vijayaraghavan R, et al. Extraction and crosslinking of bromelain aggregates for improved stability and reusability from pineapple processing waste. Int J Biol Macromol. 2020Sep;158:318–326. DOI:https://doi.org/10.1016/J.IJBIOMAC.2020.04.220
- Arshad ZIM, Amid A, Yusof F, et al. Bromelain: an overview of industrial application and purification strategies. Appl Microbiol Biotechnol. Sep. 01, 2014;98(17):7283–7297. DOI:https://doi.org/10.1007/s00253-014-5889-y. Springer Verlag.
- Mamo J, Assefa F. Antibacterial and anticancer property of bromelain: a plant protease enzyme from pineapples (ananas comosus). Current Trends in Biomedical Engineering & Biosciences. 2019;19. DOI:https://doi.org/10.19080/CTBEB.2019.19.556009
- Bakare AO, Owoyele BV. Bromelain reduced pro-inflammatory mediators as a common pathway that mediate antinociceptive and anti-anxiety effects in sciatic nerve ligated wistar rats. Sci Rep. 2021 Dec;11(1):DOI:https://doi.org/10.1038/s41598-020-79421-9.
- ZI A, A A, F Y, et al. Bromelain: an overview of industrial application and purification strategies. Appl Microbiol Biotechnol. 2014 Sep;98(17):7283–7297. DOI:https://doi.org/10.1007/S00253-014-5889-Y.
- Chaurasiya RS, Umesh Hebbar H. Extraction of bromelain from pineapple core and purification by RME and precipitation methoChaurasiyaand precipitation methods. Separation and Purifica. Sep Purif Technol. 2013Jun;111:90–97. DOI:https://doi.org/10.1016/j.seppur.2013.03.029.
- de Lencastre Novaes LC, Jozala AF, Lopes AM, et al. Stability, purification, and applications of bromelain: a review. Biotechnol Prog. 2016 Jan;32(1):5–13. DOI:https://doi.org/10.1002/btpr.2190.
- Wan J, Guo J, Miao Z, et al. Reverse micellar extraction of bromelain from pineapple peel - Effect of surfactant structure. Food Chem. 2016 Apr;197(Pt A):450–456. DOI:https://doi.org/10.1016/j.foodchem.2015.10.145.
- Amini A, Masoumi-Moghaddam S, and Morris DL. Utility of bromelain and N-acetylcysteine in treatment of peritoneal dissemination of gastrointestinal mucin-producing malignancies. Util Bromelain N-Acetylcysteine Treat Perit Dissem Gastrointest Mucin-Producing Malig. 2016 Jan;1–229. DOI:https://doi.org/10.1007/978-3-319-28570-2.
- Bhui K, Tyagi S, Srivastava AK, et al. Bromelain inhibits nuclear factor kappa-B translocation, driving human epidermoid carcinoma A431 and melanoma A375 cells through G 2/M arrest to apoptosis. Mol Carcinog. 2012 Mar;51(3):231–243. DOI:https://doi.org/10.1002/MC.20769.
- Bhui K, Tyagi S, Srivastava AK, et al. Bromelain inhibits nuclear factor kappa-B translocation, driving human epidermoid carcinoma A431 and melanoma A375 cells through G2/M arrest to apoptosis. molecular Carcinogenesis. 2012 Mar;51(3):231–243. DOI:https://doi.org/10.1002/mc.20769.
- Béez R, Lopes MTP, Salas CE, et al. In vivo antitumoral activity of stem pineapple (Ananas comosus) bromelain. Planta Med. 2007 Oct;73(13):1377–1383. DOI:https://doi.org/10.1055/S-2007-990221.
- Bhatnagar P, Pant AB, Shukla Y, et al. Bromelain nanoparticles protect against 7,12-dimethylbenz[a]anthracene induced skin carcinogenesis in mouse model. Eur J Pharm Biopharm. 2015;91:35–46.
- “MEDIWOUND LTD Company Profile | YAVNE, Israel | competitors, Financials & Contacts - Dun & Bradstreet.” https://www.dnb.com/business-directory/company-profiles.mediwound_ltd.ee85441b537aeb07662bbfd76f2f7cdf.html (accessed Feb. 01, 2022).
- Shoham Y, Krieger Y, and Tamir E, et al. Bromelain-based enzymatic debridement of chronic wounds: a preliminary report. Int Wound J. 2018 Oct;15(5):769–775. DOI:https://doi.org/10.1111/IWJ.12925.
- Valle SJ, Akhter J, Mekkawy AH, et al. A novel treatment of bromelain and acetylcysteine (BromAc) in patients with peritoneal mucinous tumours: a phase I first in man study. Eur J Surg Oncol. 2021 Jan;47(1):115–122. DOI:https://doi.org/10.1016/J.EJSO.2019.10.033.
- Amini A, Masoumi-Moghaddam S, Ehteda A, et al. Bromelain and N-acetylcysteine inhibit proliferation and survival of gastrointestinal cancer cells in vitro: significance of combination therapy. J Exp Clin Cancer Res. 2014;33(1). DOI:https://doi.org/10.1186/S13046-014-0092-7.
- Palmisano F, Spinelli M, Luzzago S, et al. Medical expulsive therapy for symptomatic distal ureter stones: is the combination of bromelain and tamsulosin more effective than tamsulosin alone? preliminary results of a single-center study. Urol Int. 2019 Mar;102(2):145–152. DOI:https://doi.org/10.1159/000493158.
- Rathnavelu V, Alitheen NB, Sohila S, et al. Potential role of bromelain in clinical and therapeutic applications (review). Biomed Rep.Sep. 01, 2016; 5(3):283–288. DOI:https://doi.org/10.3892/br.2016.720. Biomed Rep.
- Manzoor Z, Nawaz A, Mukhtar H, et al. Bromelain: methods of extraction, purification and therapeutic applications. Brazilian Arch Biol Technol. 2016Jan;59:1–16. DOI:https://doi.org/10.1590/1678-4324-2016150010.
- Errasti ME, Prospitti A, and Viana CA, et al. Effects on fibrinogen, fibrin, and blood coagulation of proteolytic extracts from fruits of Pseudananas macrodontes, Bromelia balansae, and B. hieronymi (Bromeliaceae) in comparison with bromelain. Blood Coagul Fibrinolysis. 2016 Jun;27(4):441–449. DOI:https://doi.org/10.1097/MBC.0000000000000531.
- H K, K C, C L, et al. Bromelain has paradoxical effects on blood coagulability: a study using thromboelastography. Blood Coagul Fibrinolysis. 2016 Oct;27(7):745–752. DOI:https://doi.org/10.1097/MBC.0000000000000244.
- Secor ER, Shah SJ, Guernsey LA, et al. Bromelain limits airway inflammation in an ovalbumin-induced murine model of established asthma. Altern Ther Health Med. 2012;18(5):9–17.
- K C, AB V, FA M. Bromelain’s activity and potential as an anti-cancer agent: current evidence and perspectives. Cancer Lett. 2010 Apr;290(2):148–156. DOI:https://doi.org/10.1016/J.CANLET.2009.08.001.
- Insuan O, Janchai P, Thongchuai B, et al. Anti-inflammatory effect of pineapple rhizome bromelain through downregulation of the NF-κB-and MAPKs-signaling pathways in lipopolysaccharide (LPS)-stimulated RAW264.7 cells. Curr Issues Mol Biol. 2021 Jun;43(1):93–106. DOI:https://doi.org/10.3390/cimb43010008.
- Juhasz B, Thirunavukkarasu M, Pant R, et al. Bromelain induces cardioprotection against ischemia-reperfusion injury through Akt/FOXO pathway in rat myocardium. Am J Physiol Heart Circ Physiol. 2008 Mar;294(3). DOI:https://doi.org/10.1152/AJPHEART.01005.2007.
- Atyabi F, Manoochehri S, Moghadam SH, et al. Cross-linked starch microspheres: effect of cross-linking condition on the microsphere characteristics. Arch Pharmacal Res. 2006 Dec;29(12):1179–1186. DOI:https://doi.org/10.1007/BF02969311.
- Hou RCW, Chen YS, Huang JR, et al. Cross-linked bromelain inhibits lipopolysaccharide-induced cytokine production involving cellular signaling suppression in rats. J Agric Food Chem. 2006 Mar;54(6):2193–2198. DOI:https://doi.org/10.1021/JF052390K.
- Kong T, Liu M, Ji B, et al. Role of the extracellular signal-regulated kinase 1/2 signaling pathway in ischemia-reperfusion injury. Front Physiol. 2019Aug;10:1038. DOI:https://doi.org/10.3389/FPHYS.2019.01038.
- Mynott TL, Crossett B, Prathalingam SR. Proteolytic inhibition of Salmonella enterica serovar typhimurium-induced activation of the mitogen-activated protein kinases ERK and JNK in cultured human intestinal cells. Infect Immun. 2002;70(1):86–95.
- Mynott T, Ladhams A, and Scarmato P, et al. Bromelain, from pineapple stems, proteolytically blocks activation of extracellular regulated kinase-2 in T cells. J Immunol. 1999;163(5):2568–75.
- Ugwuodo CJ, Nwagu TNT, Ugwu TT, et al. Enhancement of the anti-inflammatory effect of bromelain by its immobilization on probiotic spore of bacillus cereus. Probiotics Antimicrob Proteins. 2021 Jun;13(3):847–861. DOI:https://doi.org/10.1007/s12602-020-09714-y.
- Bakare AO, Owoyele BV. Antinociceptive and neuroprotective effects of bromelain in chronic constriction injury-induced neuropathic pain in Wistar rats. Korean J Pain. 2020;33(1):13–22.
- Adu TS, and Mabandla MV. Effects of bromelain on motor responses following intra-medial forebrain bundle 6-OHDA injection in rat model of parkinsonism. Metab Brain Dis. 2019 Dec;34(6):1557–1564. DOI:https://doi.org/10.1007/s11011-019-00462-9.
- Bernela M, Ahuja M, Thakur R. Enhancement of anti-inflammatory activity of bromelain by its encapsulation in katira gum nanoparticles. Carbohydr Polym. 2016Jun;143:18–24. DOI:https://doi.org/10.1016/j.carbpol.2016.01.055.
- Insuan O, Janchai P, and Thongchuai B, et al. Anti-Inflammatory effect of pineapple rhizome bromelain through downregulation of the nf-κb- and mapks-signaling pathways in lipopolysaccharide (lps)-stimulated raw264.7 cells. Curr Issues Mol Biol. 2021 Jun;43(1):93–106. DOI:https://doi.org/10.3390/CIMB43010008.
- Hosng JH, Kim M, Lee B, et al. Anti-inflammatory and mineralization effects of bromelain on lipopolysaccharide-induced inflammation of human dental pulp cells. Med. 2021 Jun;57(6):591. DOI:https://doi.org/10.3390/medicina57060591.
- Mehedintu C, Plotogea MN, Ionescu S, et al. Endometriosis still a challenge. J Med Life;7(3):349–357. [Sep. 15, 2014]. [Online]. Available. https://pubmed.ncbi.nlm.nih.gov/25408753/
- Agostinis C, Zorzet S, De Leo R, et al. The combination of N-Acetyl Cysteine, Alpha-Lipoic Acid, and Bromelain Shows High Anti-Inflammatory properties in novel in vivo and in vitro models of endometriosis. Mediators Inflamm. 2015;2015:1–9.
- ER S, Sj S, LA G, et al. Bromelain limits airway inflammation in an ovalbumin-induced murine model of established asthma. Altern Ther Health Med. 2012 Sep [Accessed: Jul. 10, 2021];18(5):9–17. [Online]. Available: https://pubmed.ncbi.nlm.nih.gov/22894886/
- Bhui K, Tyagi S, and Prakash B, et al. Pineapple bromelain induces autophagy, facilitating apoptotic response in mammary carcinoma cells. BioFactors. 2010 Nov;36(6):474–482. DOI:https://doi.org/10.1002/biof.121.
- Afshin A, Samar MM, and David LM, et al. Utility of bromelain and N-acetylcysteine in treatment of peritoneal dissemination of gastrointestinal mucin-producing malignancies. 1 . Cham, Switzerland: Springer International Publishing; 2016. p. XIX, 229 doi:https://doi.org/10.1007/978-3-319-28570-2.
- Bhui K, Prasad S, George J, et al. Bromelain inhibits COX-2 expression by blocking the activation of MAPK regulated NF-kappa B against skin tumor-initiation triggering mitochondrial death pathway. Cancer Lett. 2009 Sep;282(2):167–176. DOI:https://doi.org/10.1016/J.CANLET.2009.03.003.
- Raeisi F, Raeisi E, Heidarian E, et al. Bromelain inhibitory effect on colony formation: an in vitro study on human AGS, PC3, and MCF7 cancer cells. J Med Signals Sens. 2019 Oct;9(4):267–273. DOI:https://doi.org/10.4103/JMSS.JMSS_42_18.
- Kalra N, Bhui K, Roy P, et al. Regulation of p53, nuclear factor kappaB and cyclooxygenase-2 expression by bromelain through targeting mitogen-activated protein kinase pathway in mouse skin. Toxicol Appl Pharmacol. 2008 Jan;226(1):30–37. DOI:https://doi.org/10.1016/J.TAAP.2007.08.012.
- Murthy SS, Narsaiah TB. Cytotoxic effect of bromelain on HepG2 hepatocellular carcinoma cell line. Appl Biochem Biotechnol. 2021 Jun;193(6):1873–1897. DOI:https://doi.org/10.1007/S12010-021-03505-Z.
- Webb PD, Todd J. Attachment of human placental-type alkaline phosphatase via phosphatidylinositol to syncytiotrophoblast and tumour cell plasma membranes. Eur J Biochem. 1988;172(3):647–652.
- Zong ZH, Du YP, Guan X, et al. CircWHSC1 promotes ovarian cancer progression by regulating MUC1 and hTERT through sponging miR-145 and miR-1182. J Exp Clin Cancer Res. 2019 Oct;38(1):437. DOI:https://doi.org/10.1186/S13046-019-1437-Z.
- Pillai K, Akhter J, Chua TC, et al. Anticancer property of bromelain with therapeutic potential in malignant peritoneal mesothelioma. Cancer Invest. 2013 May;31(4):241–250. DOI:https://doi.org/10.3109/07357907.2013.784777.
- Amid A, Ismail NA, Yusof F, et al. Expression, purification, and characterization of a recombinant stem bromelain from Ananas comosus. Process Biochem. 2011 Dec;46(12):2232–2239. DOI:https://doi.org/10.1016/J.PROCBIO.2011.08.018.
- Fouz N, Amid A, Hashim YZHY. Gene expression analysis in MCF-7 breast cancer cells treated with recombinant bromelain. Appl Biochem Biotechnol. 2014;173(7):1618–1639.
- Morrissey JJ, Raney S. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen. Cell Biol Int. 1998;22(6):413–419.
- Dhandayuthapani S, Perez HD, Paroulek A, et al. Bromelain-induced apoptosis in GI-101A breast cancer cells. J Med Food. 2012 Apr;15(4):344–349. DOI:https://doi.org/10.1089/JMF.2011.0145.
- Amini A, Ehteda A, Masoumi Moghaddam S, et al. Cytotoxic effects of bromelain in human gastrointestinal carcinoma cell lines (MKN45, KATO-III, HT29-5F12, and HT29-5M21). Onco Targets Ther. 2013;6:403–409.
- Pauzi AZM, Yeap SK, Abu N, et al. Combination of cisplatin and bromelain exerts synergistic cytotoxic effects against breast cancer cell line MDA-MB-231 in vitro. Chin Med. 2016 Nov;11(1). DOI:https://doi.org/10.1186/S13020-016-0118-5.
- Azarkan M, Maquoi E, Delbrassine F, et al. Structures of the free and inhibitors-bound forms of bromelain and ananain from Ananas comosus stem and in vitro study of their cytotoxicity. Sci Rep. 2020 Dec;10(1). DOI:https://doi.org/10.1038/s41598-020-76172-5.
- Bhatnagar P, Patnaik S, Srivastava A, et al. Anti-Cancer activity of bromelain nanoparticles by oral administration. J Biomed Nanotechnol. 2014 Dec;10(12):3558–3575. DOI:https://doi.org/10.1166/JBN.2014.1997.
- Fouz N, Amid A, Hashim YZHY. Cytokinetic study of MCF-7 cells treated with commercial and recombinant bromelain. Asian Pacific J Cancer Prev. 2013;14(11):6709–6714.
- Song Y, Yang H, and Lin R, et al. The role of ferroptosis in digestive system cancer. Oncol Lett. Sep. 01, 2019;18(3):2159–2164. DOI:https://doi.org/10.3892/ol.2019.10568. Oncol Lett .
- Majumder D, Debnath R, Nath P, et al. Bromelain and Olea europaea (L.) leaf extract mediated alleviation of benzo(a)pyrene induced lung cancer through Nrf2 and NFκB pathway. Environ Sci Pollut Res. 2021;28:47306–47326.
- Park S, Oh J, Kim M, et al. Bromelain effectively suppresses Kras-mutant colorectal cancer by stimulating ferroptosis. Animal Cells Syst. 2018 Sep;22(5):334–340. DOI:https://doi.org/10.1080/19768354.2018.1512521. (Seoul)
- Beuth J, Van Leendert R, Schneider B, et al. Complementary medicine on side-effects of adjuvant hormone therapy in patients with breast cancer. Vivo (Brooklyn). 2013;27(6):869–871. [Accessed: Jul. 10, 2021]. [Online]. Available: https://pubmed.ncbi.nlm.nih.gov/24292594/
- Desideri I, Francolini G, Becherini C, et al. Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera®) for chemotherapy-induced peripheral neuropathy management, a prospective study. Med Oncol. 2017 Mar;34(3). DOI:https://doi.org/10.1007/s12032-017-0907-4.
- Aö Ş, S S, G S, et al. Protective effect of bromelain on corrosive burn in rats. Burns. 2020. DOI:https://doi.org/10.1016/J.BURNS.2020.12.006.